View in EDS HTML Full Text PDF Full Text

"I would never go to the doctor and speak about steroids": Anabolic androgenic steroids, stigma and harm.

Saved in:
Bibliographic Details
Title: "I would never go to the doctor and speak about steroids": Anabolic androgenic steroids, stigma and harm.
Authors: Cox, Luke (AUTHOR), Piatkowski, Timothy (AUTHOR), McVeigh, Jim (AUTHOR)
Source: Drugs: Education, Prevention & Policy. Oct2025, Vol. 32 Issue 5, p403-415. 13p.
Subjects: Androgens, Health services accessibility, Health literacy, Consumer attitudes, Anabolic steroids, Interviewing, Primary health care, Psychology of drug abusers, Harm reduction, Syringes, Ethics committees, Public health, Hypodermic needles, Social stigma, Ergogenic aids, Drugs of abuse
Abstract: Background: This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Responding to associated health risks, within the UK, harm reduction and healthcare service provisions have been established. Although these services provide essential support, various barriers, including stigma, exist which can limit engagement with them. Method: Ten qualitative interviews were conducted with PWU-AAS and have accessed healthcare and harm reduction services related to their use of AAS. Results: PWU-AAS anticipated stigma: (1) when accessing needle and syringe programs; (2) when seeking support from healthcare professionals; and (3) when experiencing specific adverse health implications. Stigma meant PWU-AAS were less likely to engage with healthcare professionals, attend harm reduction services, and were reluctant to disclose specific medial conditions. Conclusions: Interventions and messaging tackling AAS-related stigma ought to be considered for public-facing health and harm reduction services, to better support the needs and requirements of PWU-AAS. [ABSTRACT FROM AUTHOR]
Copyright of Drugs: Education, Prevention & Policy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 188176698
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: "I would never go to the doctor and speak about steroids": Anabolic androgenic steroids, stigma and harm.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Cox%2C+Luke%22">Cox, Luke</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Piatkowski%2C+Timothy%22">Piatkowski, Timothy</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McVeigh%2C+Jim%22">McVeigh, Jim</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Drugs%3A+Education%2C+Prevention+%26+Policy%22">Drugs: Education, Prevention & Policy</searchLink>. Oct2025, Vol. 32 Issue 5, p403-415. 13p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Androgens%22">Androgens</searchLink><br /><searchLink fieldCode="DE" term="%22Health+services+accessibility%22">Health services accessibility</searchLink><br /><searchLink fieldCode="DE" term="%22Health+literacy%22">Health literacy</searchLink><br /><searchLink fieldCode="DE" term="%22Consumer+attitudes%22">Consumer attitudes</searchLink><br /><searchLink fieldCode="DE" term="%22Anabolic+steroids%22">Anabolic steroids</searchLink><br /><searchLink fieldCode="DE" term="%22Interviewing%22">Interviewing</searchLink><br /><searchLink fieldCode="DE" term="%22Primary+health+care%22">Primary health care</searchLink><br /><searchLink fieldCode="DE" term="%22Psychology+of+drug+abusers%22">Psychology of drug abusers</searchLink><br /><searchLink fieldCode="DE" term="%22Harm+reduction%22">Harm reduction</searchLink><br /><searchLink fieldCode="DE" term="%22Syringes%22">Syringes</searchLink><br /><searchLink fieldCode="DE" term="%22Ethics+committees%22">Ethics committees</searchLink><br /><searchLink fieldCode="DE" term="%22Public+health%22">Public health</searchLink><br /><searchLink fieldCode="DE" term="%22Hypodermic+needles%22">Hypodermic needles</searchLink><br /><searchLink fieldCode="DE" term="%22Social+stigma%22">Social stigma</searchLink><br /><searchLink fieldCode="DE" term="%22Ergogenic+aids%22">Ergogenic aids</searchLink><br /><searchLink fieldCode="DE" term="%22Drugs+of+abuse%22">Drugs of abuse</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Responding to associated health risks, within the UK, harm reduction and healthcare service provisions have been established. Although these services provide essential support, various barriers, including stigma, exist which can limit engagement with them. Method: Ten qualitative interviews were conducted with PWU-AAS and have accessed healthcare and harm reduction services related to their use of AAS. Results: PWU-AAS anticipated stigma: (1) when accessing needle and syringe programs; (2) when seeking support from healthcare professionals; and (3) when experiencing specific adverse health implications. Stigma meant PWU-AAS were less likely to engage with healthcare professionals, attend harm reduction services, and were reluctant to disclose specific medial conditions. Conclusions: Interventions and messaging tackling AAS-related stigma ought to be considered for public-facing health and harm reduction services, to better support the needs and requirements of PWU-AAS. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Drugs: Education, Prevention & Policy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=188176698
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09687637.2024.2373056
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 403
    Subjects:
      – SubjectFull: Androgens
        Type: general
      – SubjectFull: Health services accessibility
        Type: general
      – SubjectFull: Health literacy
        Type: general
      – SubjectFull: Consumer attitudes
        Type: general
      – SubjectFull: Anabolic steroids
        Type: general
      – SubjectFull: Interviewing
        Type: general
      – SubjectFull: Primary health care
        Type: general
      – SubjectFull: Psychology of drug abusers
        Type: general
      – SubjectFull: Harm reduction
        Type: general
      – SubjectFull: Syringes
        Type: general
      – SubjectFull: Ethics committees
        Type: general
      – SubjectFull: Public health
        Type: general
      – SubjectFull: Hypodermic needles
        Type: general
      – SubjectFull: Social stigma
        Type: general
      – SubjectFull: Ergogenic aids
        Type: general
      – SubjectFull: Drugs of abuse
        Type: general
    Titles:
      – TitleFull: "I would never go to the doctor and speak about steroids": Anabolic androgenic steroids, stigma and harm.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cox, Luke
      – PersonEntity:
          Name:
            NameFull: Piatkowski, Timothy
      – PersonEntity:
          Name:
            NameFull: McVeigh, Jim
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09687637
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Drugs: Education, Prevention & Policy
              Type: main
ResultId 1